Skip navigation

Pfizer earnings beat forecasts as drugmaker plans split

(Reuters) - Pfizer Inc <PFE.N> reported second-quarter earnings slightly ahead of forecasts on Tuesday as the United States' largest drugmaker lines up a business split that could lead to the spin-off of its generics division.Full story

Ranbaxy to resume generic Lipitor production for U.S

(Reuters) - Indian generic drugmaker Ranbaxy Laboratories Ltd said on Friday it will resume production of its version of Pfizer's cholesterol fighter Lipitor for sale in the United States after resolving the issues that led to a November recall. Full story

New coupons aim to keep people off generic drugs

If brand-name prescription medicines cost you as little as generic pills, which would you choose? A few drugmakers are betting Americans will stick with the name they know. Full story

Sponsored Links
advertisement | ad info